INSUGEN? R
Product Description
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Biocon Limited (99)
-
Product Insugen 50/50 Refil ?
Biocon offers a wide range of metabolic which includes insugen 50/50 refil ?. Composition: insulin biphasic, 50% soluble and 50% nph ? 3 ml cartridge of 100 iu/ml strength. In use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn... -
Product Insugen N Refil ?
Biocon offers a wide range of metabolic which includes insugen n refil ?. Composition: isophane insulin (nph) ? 3 ml cartridge of 100 iu/ml strength. In use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the fo... -
Product Insugen R Refil ?
Biocon offers a wide range of metabolic which includes insugen r refil ?. Composition: soluble/regular insulin ? 3 ml cartridge of 100 iu/ml strength. In use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the f... -
Product INSUGEN? 30/70
Biocon offers a wide range of metabolic which includes insugen 30/70. Composition: insulin biphasic, 30% soluble and 70% nph - 10ml vials of 100 iu/ml strength. In use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is util... -
Product INSUGEN? 50/50
Biocon offers a wide range of metabolic which includes insugen 50/50. Composition: 50% soluble and 50% nph - 10ml vials of 100 iu/ml strength. In use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the form o... -
Product INSUGEN? N
Biocon offers a wide range of metabolic which includes insugen n. Composition: isophane (nph) insulin - 10ml vials of 100 iu/ml strength, in use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the form of ene... -
Product INSUPen?
Biocon offers a wide range of metabolic which includes insupen?. It is a reusable insulin pen that can deliver insulin doses from 1 unit (0.01ml) to 60 units (0.60 ml) in increments of 1 unit, available in 3 colours (blue, red and gold), manufactured for biocon at germany by haselmeier. Indications: all pa... -
Product IVNEX?-SN
Biocon offers a wide range of comprehensive care which includes ivnex-sn. Composition: each vial contains: human normal immunoglobulin? 5000mg (5gms), maltose (as stabilizer) ? 10000mg, water for injection ? q.s. Mechanism of action: antibodies to cytokines, neutralizing antibodies, normalization of t-cell... -
Product KOOLISTIN?1MIU
Biocon offers a wide range of comprehensive care which includes koolistin?1miu. Composition: each vial contains: colistimethate sodium bp 1,000,000 i. Mechanism of action: colistimethate sodium is a cyclic polypeptide antibiotic derived from bacillus polymyxa var. Colistinus and belongs to the polymyxin gr... -
Product KOOLISTIN?2MIU
Biocon offers a wide range of comprehensive care which includes koolistin?2miu. Composition: each vial contains: colistimethate sodium bp 2,000,000 iu. Mechanism of action: colistimethate sodium is a cyclic polypeptide antibiotic derived from bacillus polymyxa var. Colistinus and belongs to the polymyxin g... -
Product Matabac?
Biocon offers a wide range of comprehensive care which includes matabac. Composition: each vial contains sulbactam sodium usp (sterile) equivalent to sulbactam 1000 mg. Mechanism of action: sulbactam is a penicillanic acid sulfone with beta-lactamase inhibitory properties. Sulbactam attaches to certain pen... -
Product METADOZE? IPR
Biocon offers a wide range of metabolic which includes metadoze ipr. Composition: metformin 850mg tablets with ipr (immediate and patterned release technology) and metformin 500mg tablets with ipr (immediate and patterned release technology). Mechanism of action: metformin, belonging to the class of anti-d...
Biocon Limited resources (1)
-
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance